CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 12 filers reported holding CAN-FITE BIOPHARMA LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $358,000 | +26.1% | 409,507 | +81.6% | 0.00% | – |
| Q4 2018 | $284,000 | +15.0% | 225,509 | +17.6% | 0.00% | – |
| Q3 2018 | $247,000 | +42.8% | 191,709 | +30.6% | 0.00% | – |
| Q2 2018 | $173,000 | +7.5% | 146,800 | +31.1% | 0.00% | – |
| Q1 2018 | $161,000 | +66.0% | 112,000 | +70.5% | 0.00% | – |
| Q4 2017 | $97,000 | +38.6% | 65,700 | +57.9% | 0.00% | – |
| Q3 2017 | $70,000 | +218.2% | 41,600 | +238.2% | 0.00% | – |
| Q2 2017 | $22,000 | +1000.0% | 12,300 | +1130.0% | 0.00% | – |
| Q1 2017 | $2,000 | -83.3% | 1,000 | -80.8% | 0.00% | – |
| Q4 2016 | $12,000 | -14.3% | 5,200 | -3.7% | 0.00% | – |
| Q3 2016 | $14,000 | 0.0% | 5,400 | -3.1% | 0.00% | – |
| Q2 2016 | $14,000 | -98.0% | 5,570 | -97.7% | 0.00% | – |
| Q4 2015 | $705,000 | +103.2% | 241,586 | +188.4% | 0.00% | – |
| Q3 2015 | $347,000 | +6840.0% | 83,760 | +5417.8% | 0.00% | – |
| Q4 2014 | $5,000 | -93.8% | 1,518 | -90.4% | 0.00% | – |
| Q1 2014 | $80,000 | +81.8% | 15,881 | +116.7% | 0.00% | – |
| Q4 2013 | $44,000 | – | 7,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TAYLOR ASSET MANAGEMENT INC | 348,500 | $763,000 | 0.14% |
| MENTA CAPITAL LLC | 12,200 | $27,000 | 0.00% |
| Virtu KCG Holdings LLC | 22,042 | $48,000 | 0.00% |
| MSI Financial Services Inc | 2,000 | $4,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 458 | $1,000 | 0.00% |
| UBS Group AG | 5,194 | $11,000 | 0.00% |
| CITIGROUP INC | 17 | $0 | 0.00% |